Press Releases

;

Statement on reported cuts & changes to CDC HIV prevention programs

Mar 19, 2025

We cannot end HIV without a fully functioning and sufficiently funded HIV prevention program. If the administration has new ideas on how to conduct HIV prevention, including testing, surveillance, education and PrEP outreach, we are more than willing to discuss them. While we are making progress in reducing the number of new cases, and saving billions of dollars in the process, we must do better—32,000 new infections each year is far too many. But we cannot unilaterally cut the funding that Congress has appropriated and that states, local governments, and community-based organizations rely on to carry out their public health responsibilities to address HIV and other infectious diseases. Without those federal resources, the number of new cases and the lifetime costs of treating them will just, sadly, multiply.

read more

20 HIV & hepatitis organizations urge the U.S. Supreme Court to protect preventive services coverage

Feb 25, 2025

“Coverage of no-cost preventive services, including HIV and hepatitis testing, along with PrEP, now rests with the highest court in the land. In our brief we laid out the critical role testing plays in linking people to life-saving medications and, in the case of hepatitis C, curative treatment, along with the importance of people knowing if they have an infectious disease. We describe the growing importance of PrEP in preventing HIV, including long-acting PrEP drugs which are almost 100 percent effective in preventing HIV,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “We emphasize that coverage of preventive services by private insurers will help end HIV and hepatitis and losing them would certainly damage the public health of our country and increase medical costs.”

read more

HIV+Hep welcomes new HHS Secretary

Feb 13, 2025

To deliver on the promise of eradicating HIV will require a commitment to science, properly funded public health treatment and prevention programs, and policies that support all populations impacted by HIV.  It will also require access to affordable and comprehensive health coverage, including private insurance, Medicaid and Medicare.

read more

HIV+Hep asks senators to inquire on HHS secretary nominee’s commitment to end HIV

Jan 17, 2025

The HIV+Hepatitis Policy Institute, a leading national HIV and hepatitis policy organization promoting quality and affordable healthcare for people living with or at risk for HIV, hepatitis, and other serious and chronic health conditions, is urging senators to ensure that Robert F. Kennedy Jr., President Trump’s nominee to be Secretary of Health and Human Services, will uphold a commitment to science, public health, and ending HIV through robust research, treatment, and prevention programs.

read more

Insurer agrees to add HIV drugs after discrimination complaint filed

Dec 17, 2024

“While this action is certainly welcome, the fact remains that Harvard Pilgrim removed lifesaving HIV drugs from its coverage formulary, disrupted the treatment of people living with HIV, and violated the ACA’s nondiscrimination protections,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “This demonstrates the need for greater oversight of the health insurance industry and enforcement of the safeguards in place to protect patients against the abuse of insurers.”

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest